March 15, 2023 /3BL Media/ – Direct Relief is increasing access to donated medicine to people who need it to keep chronic disease at bay but don’t have the means to pay for it. The program, called ReplenishRx, could eventually help tens of thousands of additional patients get the medicine they need to control diseases like diabetes and hypertension.

ReplenishRx is an enhanced version of a program that provided 91,000 prescriptions to more than 23,000 patients in 2022. ReplenishRx makes it easier for free clinics, community health centers, and charitable pharmacies to enroll in the program themselves, and in turn, makes it easier for providers to enroll individual patients.

ReplenishRx is a streamlined option for pharmaceutical and medical technology manufacturers to donate their products directly to safety net organizations that care for people without health insurance or other means to pay for them.

ReplenishRx provides free medicine only for people lacking any health insurance and with household income at or below 300% of the Federal poverty line. Neither patients nor private insurance companies, nor the government are billed for the medicine. People eligible for ReplenishRx assistance do not qualify for health coverage from their state’s Medicaid program and cannot afford to purchase health insurance.

Pharmaceutical companies or foundations donating medicine to ReplenishRx include AbbVie, Eli Lilly and Company, Johnson & Johnson Patient Assistance Foundation, Medicines360, and Sanofi Cares North America.

“Lilly is deeply committed to expanding access to our medicines,” said Patrik Jonsson, Executive Vice President; President, Lilly Immunology and Lilly USA; and Chief Customer Officer. “We appreciate that Direct Relief’s ReplenishRx program not only reduces administrative burdens on safety-net clinics but also streamlines the process so that patients with limited resources can get the medicines they need, when they need them.”

Lilly and Sanofi both donate insulin through ReplenishRx.

Direct Relief set up its original Replenishment program in 2008 to streamline availability of medicine to uninsured patients at safety net clinics that primarily serve uninsured patients, including Federally Qualified Health Centers and free and charitable clinics and pharmacies. The program was designed to make it easier for patients to get medicine, while improving delivery and management of inventory for safety net clinics and pharmaceutical manufacturers. It helps clinics and charitable pharmacies provide a steady supply of vital medicine to patients lacking insurance, without the need to apply to individual Patient Assistance Programs (PAPs) offered by pharmaceutical companies.

Pharmaceutical manufacturers ship donated medicine to Direct Relief’s warehouse in Santa Barbara, California. Direct Relief manages clinic enrollment, distribution logistics, and compliance oversight of the health clinics. The clinics enroll patients based on strict eligibility guidelines, track all inventory received from Direct Relief, dispense prescribed products to eligible patients, and report product usage back to Direct Relief. Direct Relief’s ReplenishRx enables manufacturers to reach a growing network of safety-net organizations.

“The program provides a consistent, steady supply of medication for patients who have no insurance, who are low-income and have diabetes or another chronic disease,” said Marisa Barnes, who runs the ReplenishRx program at Direct Relief. “We’re reducing the amount of paperwork that’s required to participate, which means more clinics and more patients will be able to take part in the program. We’re anticipating rapid growth, particularly in the provision of insulin.”

Traditional PAPs are most often used by individual patients, who seek out programs for specific drugs, apply themselves for admission and then apply for annual renewals. Many safety-net providers help patients submit and manage the paperwork or do it on their behalf. Each patient, including those enrolled by clinics, requires a separate application from each drug maker. Clinics often rely on volunteers to help patients manage the paperwork.

Direct Relief acts as a single point of contact between each clinic and all the pharmaceutical makers it works with. Each clinic requests all its donated medicine once a month for its eligible patients from Direct Relief, and each pharmaceutical company deals only with Direct Relief to distribute its donated medicine to enrolled clinics. Rather than having to continuously request refills for each drug, enrolled healthcare organizations each month report how much of a medicine they have used, and Direct Relief sends them the same amount of the drug again in a single monthly shipment.

ReplenishRx enables patients to receive medicine at the clinic during the same visit when it is prescribed, reducing the risk that the patient won’t follow through to obtain and take the medicine, and thus improving overall health outcomes.

“Direct Relief’s Replenishment Program streamlines the process of participating in manufacturers’ patient assistance programs for our low-income, uninsured patients,” said Jennifer Buxton, Acting Executive Director and Chief Operating Officer of Cape Fear Clinic Inc. in Wilmington, N.C. “But, perhaps more importantly, it removes the treatment delay by allowing our clinic to keep inventory on hand that is immediately available for use.”

“Direct Relief’s Replenishment Program has been a complete game-changer for NC MedAssist’s Free Pharmacy Program,” said Dustin Allen, Chief Operating Officer & Director of Pharmacy Operations at NC MedAssist in Charlotte, N.C., the only statewide nonprofit pharmacy in North Carolina. “By ordering medications via a single interface as opposed to four separate ones, it not only cuts down on time needed for order placement but also ensures consistent delivery of medications.”

The original Replenishment program required participating pharmacies to use pharmacy software that many of the smallest healthcare organizations lack. Under ReplenishRx, enrolled organizations can upload the necessary information from their electronic health record systems, allowing a wider degree of participation.

Direct Relief has also made it faster and easier for small healthcare organizations to enroll in the program. Under the original program, it could take eight months to a year for an organization to develop and document the standard operating procedures needed to ensure compliance with donation program requirements, which differ among pharma companies. Direct Relief has now developed a Standard Operating Procedures manual that healthcare organizations can integrate into their processes.

ReplenishRx is just one of the many ways Direct Relief provides support to health centers, free and charitable clinics and charitable pharmacies. Direct Relief’s core Safety Net Program donates medicine and medical supplies to more than 1,300 health clinic and charitable pharmacy locations. The program allows them to request donations of specific drugs, which Direct Relief allocates according to available supply and the number of patients each organization serves. In 2022, the Safety Net Program donated medicine with a wholesale value of $258 million. All the medicine Direct Relief donates to these organizations can be dispensed only to low-income patients lacking any health insurance.

Originally published on U.S. Bank company blog

For the eighth consecutive year, U.S. Bank has been named one of the World’s Most Ethical Companies by the Ethisphere Institute, a global leader in defining and advancing the standards of ethical business practices.

“Our employees have gone above and beyond to support our communities and customers.” said Andy Cecere, chairman, president and chief executive officer. “They work hard to earn and keep our customers’ trust, and this honor belongs to them.”

Ethisphere recognized 136 honorees that span 22 countries and 45 industries. U.S. Bank is one of five honorees in the banking category.

“Acting with integrity is who we are as a company,” said Katie Lawler, global chief ethics officer. “Our commitment to the communities we serve and the care our employees show for each other inspires me.”

The World’s Most Ethical Companies assessment is based on Ethisphere’s Ethics Quotient® framework. It includes more than 200 questions on culture, environmental and social practices, ethics and compliance activities, governance, diversity and initiatives to support a strong value chain. The process captures and codifies the leading practices of organizations across industries and around the globe. This year, the question also gauged how applicants are adapting and responding to the global health pandemic, environmental, social, and governance factors, safety, equity, and inclusion and social justice.

“Today, business leaders face their greatest mandate yet to be ethical, accountable, and trusted to drive positive change,” said Ethisphere CEO Timothy Erblich. “We continue to be inspired by the World’s Most Ethical Companies honorees and their dedication to integrity, sustainability, governance, and community. Congratulations to U.S. Bank for earning the World’s Most Ethical Companies designation.”

About U.S. Bank
U.S. Bancorp, with nearly 70,000 employees and $573 billion in assets as of December 31, 2021, is the parent company of U.S. Bank National Association, the fifth-largest commercial bank in the United States. The Minneapolis-based bank blends its relationship teams, branches and ATM network with mobile and online tools that allow customers to bank how, when and where they prefer. U.S. Bank is committed to serving its millions of retail, business, wealth management, payment, commercial and corporate, and investment services customers across the country and around the world as a trusted financial partner, a commitment recognized by the Ethisphere Institute naming the bank one of the 2022 World’s Most Ethical Companies. Learn more at usbank.com

About Ethisphere 
Ethisphere® is the global leader in defining and advancing the standards of ethical business practices that fuel corporate character, marketplace trust and business success. Ethisphere has deep expertise in measuring and defining core ethics standards using data-driven insights that help companies enhance corporate character and measure and improve culture. Ethisphere honors superior achievement through its World’s Most Ethical Companies recognition program and provides a community of industry experts with the Business Ethics Leadership Alliance (BELA). More information about Ethisphere can be found at: https://ethisphere.com.

Contact:

Cheryl Leamon, U.S. Bank

651.435.7460, cheryl.leamon@usbank.com

Anne Walker, Ethisphere

Anne.Walker@Ethisphere.com

 

Occupational health and safety

We are committed to achieving zero serious injuries for employees and contractors. Our safety target, which we restated in our Vision 2030 goals, is non-negotiable, and is a shared responsibility: We look out for each other to ensure everyone returns home safely every day.

Our Life-changing Injury and Fatality Elimination (LIFE) program engages employees and fosters a learning culture to advance an injury-free workplace. By focusing on five key areas of workplace risk — slips, trips and falls; machine safeguarding; harmful substance exposure; motorized equipment accidents; and driver safety — our goal is to eliminate serious injuries and reduce all injuries to zero.

Our global operations report quarterly on safety leading indicators to all employees, including our senior lead team. With this data, we are able to measure the effectiveness of our health and safety initiatives and allocate resources to areas of safety that need to be improved. In 2021, International Paper continued actions tracked against the safety leading indicators, such as contact coordinator training and safe work observations to maintain LIFE performance year-over-year, despite ongoing distractions created by the global pandemic.

In 2021, 94% of our sites operated without a serious injury, reinforcing the positive impact of our programs. Still, we are committed to continuing to find safe ways to practice safety leadership, ensure layers of protection and take the necessary steps to keep ourselves and each other safe and healthy.

Safety leadership

Our safety culture reflects our belief that every employee is a safety leader regardless of his or her role. This means that each of us is required to:

Maintain an active safety mindset
Anticipate, recognize and remove hazards
Intervene in unsafe conditions
Contribute to a learning culture where we learn from events and near misses
Integrate layers of protection — devices, systems and actions that combine to reduce the likelihood and severity of an unsafe event in our work
Take responsibility and be accountable

Our Response to the Continuing COVID-19 Crisis

The COVID-19 pandemic continued to generate global health and economic challenges in 2021. Our commitment to keep our colleagues safe, meet the critical needs of our communities and deliver essential products to our customers never wavered. Our initiatives included:

On-site vaccination clinics where possible as well as information on community clinics
Education materials explaining the benefits of vaccination to employees and links to where they could learn more
Video interviews with subject matter experts to address COVID-19 facts and myths, with topics such as herd immunity and vaccine development
Continued implementation of pandemic preparedness plans, including processes and procedures for proper personal protective equipment requirements, social distancing and enhanced cleaning

About International Paper
International Paper (NYSE: IP) is a leading global supplier of renewable fiber-based products. We produce corrugated packaging products that protect and promote goods, and enable worldwide commerce, and pulp for diapers, tissue and other personal care products that promote health and wellness. Headquartered in Memphis, Tenn., we employ approximately 38,000 colleagues globally. We serve customers worldwide, with manufacturing operations in North America, Latin America, North Africa and Europe. Net sales for 2021 were $19.4 billion. See how we’re building a better future for people, the planet, and our company at internationalpaper.com/Vision-2030.

Read more

DUBLIN, March 15, 2023 /PRNewswire/ — The “Generic Pharmaceuticals Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.